Scientists discover why Ozempic and Wegovy weight loss eventually plateaus

Researchers at the National Institutes of Health (NIH) have uncovered new details about how GLP-1 weight loss drugs such as semaglutide affect brain cells, revealing internal signaling processes that scientists have only begun to understand. The…

Continue Reading

News Source: www.sciencedaily.com